We previously reported on the essential role played by PR55α-controlled PP2A in the activation of oncogenic pathways involving ERK, YAP, β-catenin, and c-Myc, all of which are known to be essential for pancreatic cancer tumorigenesis and progression [23–26]. The gene discussed is MYC; the disease is pancreatic neoplasm.